Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807904) titled 'NanoSALV vs Standard Topical Care Pathway in Sports-Related Skin Lesions' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Shahab Alizadeh

Condition: Blister of Foot Blister

Intervention: Device: NanoSALV Catalytic

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 1, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07807904

Disclaimer: Curated by HT Syndication....